CLC Number:
| [1] Tan PH, Tse G, Lee A, et al. Fibroepithelial tumours[M] // Lakhani SR, Ellis IO, Schnitt SJ, et al. WHO Classification of Tumours of the Breast. 4th edn. Lyon: International Agency for Research on Cancer(IARC), 2012: 141-147. [2] Karim RZ, Gerega SK, Yang YH, et al. Phyllodes tumours of the breast: a clinicopathological analysis of 65 cases from a single institution [J]. Breast, 2009, 18(3): 165-170. [3] Kim S, Kim JY, Kim DH, et al. Analysis of phyllodes tumor recurrence according to the histologic grade[J]. Breast Cancer Res Treat, 2013, 141(3): 353-363. [4] 付丽,傅西林.乳腺肿瘤病理学[M].北京:人民卫生出版社, 2008: 207-211. [5] Barrio AV, Clark BD, Goldberg JI, et al. Clinicopathologic features and long-term outcomes of 293 phyllodes tumors of the breast[J]. Ann Surg Oncol, 2007, 14(10): 2961-2970. [6] Reinfuss M, Mitus J, Duda K, et al. The treatment and prognosis of patients with phyllodes tumor of the breast: an analysis of 170 cases [J]. Cancer, 1996, 77(5): 910-916. [7] Krings G, Bean GR, Chen YY. Fibroepithelial lesions; The WHO Spectrum[J]. Semin Diagn Pathol, 2017, 34(5): 438-452. [8] Mangi AA, Smith BL, Gadd MA, et al. Surgical management of phyllodes tumors[J]. Arch Surg, 1999, 134(5): 487-492; discussion 492-493. [9] 肖颖,阮秋蓉.乳腺叶状肿瘤的临床病理特征及研究进展[J].中华病理学杂志, 2013, 42(11): 783-785. [10] Guillot E, Couturaud B, Reyal F, et al. Management of phyllodes breast tumors[J]. Breast J, 2011, 17(2): 129-137. [11] Duman L, Gezer NS, Balci P, et al. Differentiation between phyllodes tumours and fibroadenomas based on mammographic sonographic and MRI findings [J]. Breast Care(Basel), 2016, 11(2): 123-127. [12] Chen WH, Cheng SP, Tzen CY, et al. Surgical treatment of phyllodes tumors of the breast: retrospective review of 172 cases [J]. J Surg Oncol, 2005, 91(3): 185-194. [13] Jacklin RK, Ridgway PF, Ziprin P, et al. Optimising preoperative diagnosis in phyllodes tumour of the breast [J]. J Clin Pathol, 2006, 59(5): 454-459. [14] Choi J, Koo JS. Comparative study of histological features between core needle biopsy and surgical excision in phyllodes tumor[J]. Pathol Int, 2012, 62(2): 120-126. [15] Giri D. Recurrent challenges in the evaluation of fibroepithelial lesions [J]. Arch Pathol Lab Med, 2009, 133(5): 713-721. [16] Yang X, Kandil D, Cosar EF, et al. Fibroepithelial tumors of the breast: pathologic and immunohistochemical features and molecular mechanisms [J]. Arch Pathol Lab Med, 2014, 138(1): 25-36. |
| [1] | LI Ning, LI Juan, XIE Yan, LI Peilong, WANG Yunshan, DU Lutao, WANG Chuanxin. Expression of LncRNA AL109955.1 in 80 cases of colorectal cancer and its effect on cell proliferation, migration and invasion [J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 38-46. |
| [2] | ZHANG Peipei, LIU Dequan, WANG Bei, HE Shuqian, LI Fei, DING Hongyu, SUN Hongjun. Sonographic findings and pathological features of non-mass pure ductal carcinoma in situ [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(11): 54-58. |
| [3] | . [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(7): 130-132. |
| [4] | MENG Fanchao, FENG Lu, SHAO Guangrui. FOXM1 regulates transcription of SYK in breast cancer cell line MCF-7 [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(3): 19-24. |
| [5] | LIN Jiaxiang, GUO Zijia, SU Peng, WANG Xiao, GUO Yaxin, WU Xiaojuan, XIANG Lei, ZHOU Zhiqiang, WANG Yan, CUI Xiujie, PAN Aifeng, GUO Chenghao. The role of CIP2A in the transformation of breast ductal epithelium and prognosis of invasive breast cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(3): 100-106. |
| [6] | XU Zhihong, LIU Rongfeng, WANG Xiaoxiang, FENG Li, YAO Tiezhu, LIU Hong. Efficacy and safety of Yangzheng Xiaoji capsule combined with chemotherapy in treating metastatic breast cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(5): 79-83. |
| [7] | LI Ranran, ZHANG Pengfei, YUAN Bing, FANG Feifei, HAN Mingyong. Breast tumor deriving VEGF induces vascular endothelial cells to suppress immune functions [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(2): 38-43. |
| [8] | . [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(S2): 43-44. |
| [9] | LI Ling, WANG Lili, WANG Shengjiang, YU Chao, LIU Yanpeng, XU Chengwei. Research on the relationship between plasma D-dimer level and prognosis of breast cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(9): 77-80. |
| [10] | SUN Ying, YU Jing, WEI Junmin, FAN Cong, WANG Xiuwen, GAO Peng, JIANG Liyu, MA Tingting. Clinical and pathological characteristics of breast carcinoma in women aged 35 years or younger [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(7): 71-74. |
| [11] | . [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(5): 109-110. |
| [12] | MA Zhen-shen1, WANG Da-wei2, SUN Xiu-bin3, SHI Hao1, PANG Tao1, DONG Gui-qing1, ZHANG Cheng-qi1. Quantitative analysis of 3.0T MR in differential diagnosis of breast lesions [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(9): 79-83. |
| [13] | CHI Wei-wei1, GAO Hai-yan2, GAO Hai-dong3. The molecular mechanism of transforming growth factor-β1-induced transmembrane protein participating in the development of breast cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(4): 26-29. |
| [14] | LI Shan-shan， SUN Ying, DING Huan, LI Li. β-catenin expressions in different subtypes of breast cancer and its clinical significance [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(3): 107-110. |
| [15] |
CEN Dong-zhi.
Overexpression of NRIP3 gene inhibited metastasis in lymph node negative breast cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(9): 83-. |
|
||
